Connor, Clark & Lunn Investment Management (CC&L)’s GeneDx Holdings WGS Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21,824	Closed	-$1.4M	–	1810
2026 Q1	$1.4M	Sell	21,824 -19,217	-47%	-$1.75M	﹤0.01%	1064
2025 Q4	$5.34M	Buy	41,041 +22,535	+122%	+$3.09M	0.01%	626
2025 Q3	$1.99M	Buy	+18,506	New	+$2.02M	0.01%	854
2025 Q2	–	Sell	-84,143	Closed	-$7.45M	–	1701
2025 Q1	$7.45M	Sell	84,143 -81,951	-49%	-$7.11M	0.03%	391
2024 Q4	$12.8M	Buy	166,094 +106,089	+177%	+$7.41M	0.06%	265
2024 Q3	$2.55M	Buy	+60,005	New	+$2.03M	0.01%	613
2023 Q1	–	Sell	-571	Closed	-$4.97K	–	1476
2022 Q4	$4.97K	Buy	+571	New	+$12.6K	﹤0.01%	1175

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s WGS Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 21,824 shares — an estimated $1.4M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in WGS in Q4 2022 and held it in 7 quarters. The position peaked at $12.8M in Q4 2024. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 21,824 GeneDx Holdings shares in Q2 2026, an estimated $1.4M.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in GeneDx Holdings in Q4 2022 and held it in 7 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s GeneDx Holdings position peaked at $12.8M in Q4 2024.
223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.